Boston Scientific: latest news - GoINPHARMA
Friday, 16 November 2018 - 8:39

Boston Scientific

Boston Scientific acquires Augmenix for $600m

Boston Scientific (Massachusetts) has announced the acquisition of Augmenix, Inc. for $600m. As part of the agreement, Boston Scientific will pay Augmenix an upfront $500m, plus an additional $100m subject to fulfillment of precise milestones. Augmenix is headquartered in Bedford,…

Boston Scientific to acquire Switzerland’s Symetis for $435m (TAVR)

Boston Scientific Corp announced it has acquired Switzerland-based Symetis SA for $435m. Symetis ranks fourth globally in the replacement of heart valves – more specifically, TAVR (Transcatheter Aortic Valve Replacement). Symetis’ top brand is Acurate, which will join Boston Scientific’s…